A5030526716- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Transplantation: Methods and Outcomes
- Cardiac pacing and defibrillation studies
- Congenital Heart Disease Studies
- Renal Transplantation Outcomes and Treatments
- Cardiac Valve Diseases and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Pulmonary Hypertension Research and Treatments
- Organ Transplantation Techniques and Outcomes
- Heart Failure Treatment and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Ischemia and Reperfusion
- Viral Infections and Immunology Research
- Cardiovascular Conditions and Treatments
- Kawasaki Disease and Coronary Complications
- Cardiac and Coronary Surgery Techniques
- COVID-19 Impact on Reproduction
- Cardiomyopathy and Myosin Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Central Venous Catheters and Hemodialysis
- Redox biology and oxidative stress
- Graphene and Nanomaterials Applications
- Atherosclerosis and Cardiovascular Diseases
- Lipoproteins and Cardiovascular Health
Silesian Center for Heart Disease
2014-2024
Medical University of Silesia
2015-2024
Kardio-Med Silesia
2024
University of Opole
2020-2022
Górnośląskie Centrum Medyczne
2012-2018
Dong-A University Hospital
2015
Johns Hopkins University
2015
Wroclaw Medical University
2015
University of Baltimore
2015
Abstract OBJECTIVES A second paediatric report has been generated from the European Registry for Patients with Mechanical Circulatory Support (EUROMACS). The purpose of EUROMACS, which is operated by Association Cardio-Thoracic Surgery, to gather data related durable mechanical circulatory support scientific purposes and publish reports respect course therapy. Since first issued, efforts increase compliance participation have extended. Additionally, provided opportunity analyse patients...
Aims The aim of the present study was to isolate mesenchymal stromal cells (MSC) with CD105+CD34- phenotype from human hearts, and investigate their therapeutic potential in a mouse model hindlimb ischemia myocardial infarction (MI). aimed also feasibility xenogeneic MSCs implantation. Methods Results MSC isolated hearts were multipotent cells. Separation limited heterogeneity originally cell population. secreted number anti-inflammatory proangiogenic cytokines (mainly IL-6, IL-8, GRO)....
A third paediatric report has been generated from the European Registry for Patients with Mechanical Circulatory Support (EUROMACS). The purpose of EUROMACS, which is operated by Association Cardio-Thoracic Surgery, to gather data related durable mechanical circulatory support scientific purposes and publish reports respect course therapy. Since first issued, efforts increase compliance participation have extended. Additionally, provided opportunity analyse patients younger age lower...
This study aims to explore characteristics and clinical outcomes of patients with congenital heart disease (CHD) in the European Registry for Patients Mechanical Circulatory Support (EUROMACS).
Concomitant chronic obstructive pulmonary disease (COPD) is associated with an increased rate of post-coronary artery bypass grafting (CABG) complications. The ratio forced expiratory volume in 1 second to vital capacity (FEV1/FVC) <70%, proposed by the Global Initiative for Chronic Obstructive Lung Disease as a criterion diagnosis COPD, criticized not considering physiological, age-related changes lung function.The aim study was evaluate which additional spirometric parameters, adjusted age...
According to literature data, self-renewing, multipotent, and clonogenic cardiac c-Kit(+) progenitor cells occur within human myocardium. The aim of this study was isolate characterize from explanted hearts. Experimental material obtained 19 adult 7 pediatric patients. Successful isolation culture achieved for 95 samples (84.1%) derived five different regions the heart: right left ventricles, atrium, intraventricular septum, apex. average percentage cells, as assessed by FACS, ranged between...
Mechanical circulatory support for pediatric heart failure patients with the Berlin Heart EXCOR ventricular assist system is only approved and established bridging strategy recovery or transplantation. In recent years, burden of thromboembolic events has led to modifications recommended antithrombotic therapy. Therefore, we aimed assess practice among European Pediatric Investigator Group members.We sent a questionnaire assessing seven aspects therapy 18 hospitals using device children....
The Berlin Heart EXCOR (BHE) offers circulatory support across all paediatric ages. Clinically, the necessary care and outcomes differ in various age groups. EUROMACS database was used to study age- size-related for this specific device.All patients <19 years of from supported with a BHE between 2000 November 2021 were included. Maximally selected rank statistics determine body surface area (BSA) cut-off values. Multivariable Cox proportional hazard regression using ridge penalization...
ABSTRACT Background Predicting bleeding events in patients with coronary artery bypass grafting (CABG) represents an unmet medical need that may improve CABG outcomes. Hypotesis To assess the potential link between platelet function testing and risk undergoing CABG. Methods Platelet aggregation clinical outcomes 478 treated aspirin and/or clopidogrel were retrospectively analyzed. activity was assessed prior to arachidonic acid (ASPI Test), adenosine diphosphate(ADP Test) utilizing...
Interactions of graphene oxide (GO) with an
AMA Przybylski R, Pawlak S, Śliwka J, et al. Aortic cusp extension valvuloplasty: repair with an extracellular patch. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2015;12(4):314-317. doi:10.5114/kitp.2015.56780. APA Przybylski, R., Pawlak, S., Śliwka, J., Urlik, M., Maruszewski, & Kukulski, T. (2015). Surgery, 12(4), 314-317. https://doi.org/10.5114/kitp.2015.56780 Chicago Roman, Szymon Joanna Maciej Marcin Tomasz Jerzy Nożyński 2015....
Purpose: The withdrawal of HVAD in 2021 created a concern for the pediatric population. alternative implantable centrifugal blood pump HeartMate 3 has since been used more frequently children. This paper analyses outcome children on LVAD support provided with an or HM3. Methods: A retrospective analysis EUROMACS database supported VAD < 19 years age from 1 January 2009 to December was conducted. All patients and either HM3 were included. Patients missing data status and/or baseline follow...
Ventricular assist device support as a bridge to transplant or recovery is well-established therapy in children on the cardiac waiting list. The goal of this study was investigate incidence and associated factors for cerebrovascular accidents paediatric patients supported by Berlin Heart EXCOR.All <19 years age EXCOR between January 2011 2021 from European Registry Patients with Mechanical Circulatory Support were included.In total, 230 included. A total 140 (60.9%) had diagnosis dilated...
The treatment of advanced heart failure (HF) in children and infants poses a serious management problem. Heart that patient group is usually congenital aetiology. schedules for paediatric patients are most cases adapted from the guidelines adults. Up to 2009, extremely difficult was limited pharmacological therapy occasional transplantations. Constantly increasing problems with recruiting donors, especially group, contribute fact mechanical support use ventricular assist devices many only...
Despite advanced techniques and improved clinical outcomes, patient survival following coronary artery bypass grafting (CABG) is still a major concern. Therefore, predicting future CABG mortality represents an unmet medical need should be carefully explored. The objective of this study to assess whether pre-CABG platelet activity corresponds with 30 days post-CABG. Retrospective analyses biomarkers death at in 478 heart surgery patients withdrawn from aspirin or/and clopidogrel. Platelet was...
We present a case of 22-month-old boy with hypokinetic and thin-walled aneurysm the left ventricle apex. The lesion was diagnosed during routine echocardiography examination in course MIS-C, its occurrence due to MIS-C is plausible. Cardiac magnetic resonance imaging revealed an akinetic LV apex full-wall ischemic scar. Aortography confirmed normal coronary arteries, adequate perfusion essential branches no evidence stenosis or aneurysms. underwent consultation heart team deemed eligible for...
Abstract OBJECTIVES Myocardial recovery in children supported by a durable left ventricular assist device is rare, but highly desirable outcome because it could potentially eliminate the need for cardiac transplant and lifelong immunosuppressant therapy risk of complications. However, experience with this specific extremely limited. METHODS All patients &lt; 19 years old from European Registry Patients Mechanical Circulatory Support database were included. Participating centres...
Restrictive cardiomyopathy is rare and generally associated with worse clinical outcomes compared to other cardiomyopathies. Ventricular assist device (VAD) support for these children seldom applied often hampered by the surgical difficulties.
The use of ventricular assist devices (VADs) in children is increasing. However, absolute numbers individual centres and countries remain small. Collaborative efforts such as the Paedi-European Registry for Patients with Mechanical Circulatory Support (EUROMACS) are therefore essential combining international experience paediatric VADs. Our goal was to present results from fourth Paedi-EUROMACS report.